Healthcare
M6P Therapeutics – SUCCESS PAGE – Recorded October 23, 2024
M6P is currently developing gene and enzyme replacement options to treat Pompe disease and been granted a Rare Pediatric Drug designation.
M6P is currently developing gene and enzyme replacement options to treat Pompe disease and been granted a Rare Pediatric Drug designation.
Revolutionizing fisheries management with a digital catch reporting and seafood traceability platform for commercial fishing boats
The world-class antibody engineers at OncoOne are creating monoclonal antibodies to treat diseases with exacting specificity and precision
Deep sea nodule collection provides higher quality critical minerals with significantly lower environmental impact than traditional mining.
An anti-inflammation platform that has the potential to treat Parkinson’s, Alzheimer’s, Liver disease, Diabetes, Arthritis and more.
Element Fleet has a developed a new securitized trust that has the potential to deliver significant tax advantages
The company’s AI-powered drug development program has the potential to treat multiple CNS diseases and impact millions of lives.
GruEnergy is leveraging a breakthrough in material science to accelerate the world’s transition from fossil fuels to carbon-free power.
A precision medicine company that has uncovered the immune-mediated roots of a range of psychiatric disorders and is guiding the treatment for them
A platform of patented devices that actually improve the performance of cancer immunotherapy and chemotherapy
CH4 Global has created a natural supplement that when added to a cow’s feed, prevents methane from being produced during digestion.
Cowboy has taken cues from companies like Apple, Tesla, and Peloton to build a bike that is beautiful, easy to ride, and connected.